glp-1 seattle Oral Semaglutide Sublingual Drops for Weight Loss in How use of weight-loss drugs
Description
Eating less on Wegovy but worried about muscle loss
Tirzepatide was approved in 2022 as Mounjaro for diabetes, and in 2024 as Zepbound for obesity, with exclusivity running until May 2027
Millions of people started taking GLP-1 Drugs (Semaglutide or Tirzepatide) after the trials ended and drugs reached the market
Retatrutide Triple Agonist (GLP-1/GIP/GCG) for advanced metabolic research
GLP-1 receptor agonists can trigger heartburn and reflux in some patients by slowing stomach emptying and increasing intragastric pressure
Here's what seniors and their providers need to know...
